Investors: tie pharma CEO pay to fair global COVID-19 vaccine access

Published by

By Toby Sterling AMSTERDAM (Reuters) – A group of institutional investors representing $3.5 trillion in assets under management on Thursday called on pharmaceutical companies to link their executives’ pay to making COVID-19 vaccines available around the globe. While the majority of citizens of wealthy nations are vaccinated and many are now receiving booster shots, across the African continent vaccination rates average only around 10%. The World Health Organization has set a target of a 70% vaccination rate in every country by July 2022 in order to end the “acute phase” of the pandemic. The 65…

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *